EU authorizes AstraZeneca/Oxford COVID-19 vaccine


  • World
  • Saturday, 30 Jan 2021

BRUSSELS, Jan. 29 (Xinhua) -- The European Commission granted conditional marketing authorization for the COVID-19 vaccine developed by British company AstraZeneca and Oxford University on Friday, although the bloc seems unlikely to get the amount of doses as agreed for the moment.

"Securing safe vaccines for Europeans is our utmost priority. With the AstraZeneca vaccine now authorized, 400 million additional doses will be available in Europe," said European Commission President Ursula von der Leyen.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
   

Next In World

Swiss voters reject more powers for landlords on subletting
Italy's opposition 5-Star breaks with co-founder Grillo
Separatist commander killed in Cameroon's restive Anglophone region
Feature: Namibia's Katutura Fashion Week champions innovation, inclusivity
Four convicted in Spain over homophobic murder that sparked nationwide protests
Ukraine studies debris from new Russian ballistic missile
Iran to hold nuclear talks with three European powers in Geneva on Friday, Kyodo reports
Irish PM's party sees poll lead narrow ahead of election
Russia removes commander in Ukraine for misleading reports, war bloggers say
Islamabad locked down ahead of protests seeking ex-PM Imran Khan's release

Others Also Read